|
 |
Breast Cancer > Growth Rate Factors
The following information is about Growth Rate Factors.
Growth Rate Factors Defined
Markers used to predict the growth rate of malignant cells and the probability that the cancer will spread.
This definition is in context to Breast Cancer. See more contextual defintions for Growth Rate Factors.
Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery
Published August 27, 2008, 3:12 pm, News-Medical-Net
Novartis has announced that Gleevec (imatinib mesylate) tablets, (known as Glivec (imatinib) outside the US, Canada and Israel), has been granted priority review status by the US Food and Drug Administration (FDA) as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal stromal tumors (GIST).
Paris Express: Ara
Published August 27, 2008, 11:26 am, Paris Express
Automotive ( top ) Tips for Road Trips With Pets (ARA) - Bringing the family pet along on a road trip may seem like a good idea - you don't have to ask friends or family to look after your pet and you can avoid the costs and concerns that go with boarding and kennels.
Desert Trail - Yucca Valley, CA: Ara
Published August 27, 2008, 7:52 am, Desert Trail
Automotive ( top ) Clint Bowyer on Motorcycle Safety (ARA) - An increase of motorcycles on the road and the fact that less than half have taken an organized rider education course, indicates a need for increased awareness of proper motorcycle safety.
Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After ...
Published August 27, 2008, 4:00 am, PR Newswire via Yahoo! Finance
Novartis announced today that Gleevec® tablets* has been granted priority review status by the US Food and Drug Administration as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal stromal tumors .
Genmab Has Announced Plans To Begin Four Studies Of Ofatumumab In Chronic Lymphocytic Leukemia And Non-Hodgkin's ...
Published August 27, 2008, 3:14 am, Medical News Today
Genmab A/S (OMX: GEN) announced plans to begin four studies of ofatumumab in chronic lymphocytic leukemia (CLL) and follicular non-Hodgkin's lymphoma (NHL) this year. "Genmab and GSK have worked diligently to expand the ofatumumab development program to maximize the value of the antibody for patients and shareholders since our collaboration began," said Lisa N. Drakeman, Ph.D.
Pregnancy Situations Have Impact On Brain Development In Preterm Infants
Published August 27, 2008, 3:14 am, Medical News Today
Brain development in infants who are born very prematurely is still incomplete. Factors that cause premature birth may have an impact on the development of the premature infant's brain both during pregnancy and later on after birth.
LETTERS TO THE EDITOR
Published August 27, 2008, 12:57 am, Santa Fe Reporter
Plastic is Poison I was extremely disappointed in the plastic bottle and water article last week [ Cover story, Aug. 12: “H2 Woe” ] and saw it as yet another example of scientific illiteracy in the popular media (Zane’s comments about Wi-Fi a bit ago were another).
Scotiabank earnings top $1 billion in solid third quarter
Published August 26, 2008, 8:23 am, PR Newswire via Yahoo! Finance
Earnings per share of $0.98 compared to $1.02 last year and
New Trial To Evaluate Nexavar® As Adjuvant Therapy In Liver Cancer
Published August 26, 2008, 6:15 am, Medical News Today
Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. announced the start of a Phase III study with Nexavar® (sorafenib) tablets in liver cancer. The randomized, double-blind, placebo-controlled study is evaluating Nexavar as an adjuvant therapy for patients with hepatocellular carcinoma (HCC), or primary liver cancer.
Normalizing Tumor Vessels To Improve Cancer Therapy
Published August 26, 2008, 6:14 am, Medical News Today
Chemotherapy drugs often never reach the tumors they're intended to treat, and radiation therapy is not always effective, because the blood vessels feeding the tumors are abnormal "leaky and twisty" in the words of the late Judah Folkman, MD, founder of the Vascular Biology program at Children's Hospital Boston.
Are you looking for additional Breast Cancer > Growth Rate Factors news? Try our new "Growth Rate Factors News Focus" area.
Social bookmarks are not available at the moment.
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Growth Rate Factors. If you would like to find related tags we recommend Tag Patterns > Growth Rate Factors
Off-site Growth Rate Factors Research Links
If you still need additional information on Growth Rate Factors then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
- A9 > Growth Rate Factors
- Alexa > Growth Rate Factors
- Anti-Aging Revolution > Growth Rate Factors
- DMOZ > Growth Rate Factors
- Feeds Filtered > Growth Rate Factors
- Google > Growth Rate Factors
- News Meme > Growth Rate Factors
- Nuah: News > Growth Rate Factors
- The Feed Directory > Growth Rate Factors
- OBP > Growth Rate Factors
- Open Tag Directory > Growth Rate Factors
- Podzy > Growth Rate Factors
- Yahoo > Growth Rate Factors
Breast Cancer Topics
Everything you need to know about Breast Cancer
Breast Cancer
If you know the Breast Cancer Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Breast-Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.